{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:11:15Z","timestamp":1787314275548,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,30]]},"DOI":"10.7759\/cureus.63525","type":"journal-article","created":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T16:27:10Z","timestamp":1719764830000},"source":"Crossref","is-referenced-by-count":2,"title":["Amyloidoma: A Case Report of Remote Insulin-Derived Amyloidosis in the Setting of Insulin-Dependent Diabetes"],"prefix":"10.7759","author":[{"given":"Daniel","family":"Duong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia","family":"Westhoff-Pankratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Frugoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Pajuleras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Ta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Barrows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.5493","article-title":"Systemic amyloidosis recognition, prognosis, and therapy: a systematic review","volume":"324","author":"Gertz MA","year":"2020","unstructured":"Gertz MA, Dispenzieri A. Systemic amyloidosis recognition, prognosis, and therapy: a systematic review. JAMA. 2020, 324:79-89. 10.1001\/jama.2020.5493","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000002263","article-title":"Cutaneous ossifying amyloidoma","volume":"44","author":"Requena C","year":"2022","unstructured":"Requena C, Diago A, Traves V, Llombart B, Nagore E, Sanmartin O. Cutaneous ossifying amyloidoma. Am J Dermatopathol. 2022, 44:760-3. 10.1097\/DAD.0000000000002263","journal-title":"Am J Dermatopathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M406853200","article-title":"Identifying structural features of fibrillar islet amyloid polypeptide using site-directed spin labeling","volume":"279","author":"Jayasinghe SA","year":"2004","unstructured":"Jayasinghe SA, Langen R. Identifying structural features of fibrillar islet amyloid polypeptide using site-directed spin labeling. J Biol Chem. 2004, 279:48420-5. 10.1074\/jbc.M406853200","journal-title":"J Biol Chem"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2005.10.052","article-title":"Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP?","volume":"355","author":"Abedini A","year":"2006","unstructured":"Abedini A, Raleigh DP. Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP?. J Mol Biol. 2006, 355:274-81. 10.1016\/j.jmb.2005.10.052","journal-title":"J Mol Biol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.03.001","article-title":"Nodular amyloidosis in a diabetic patient with frequent hypoglycemia: sequelae of repeatedly injecting insulin without site rotation","volume":"63","author":"Endo JO","year":"2010","unstructured":"Endo JO, R\u00f6cken C, Lamb S, Harris RM, Bowen AR. Nodular amyloidosis in a diabetic patient with frequent hypoglycemia: sequelae of repeatedly injecting insulin without site rotation. J Am Acad Dermatol. 2010, 63:e113-4. 10.1016\/j.jaad.2010.03.001","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.02.011","article-title":"Insulin-derived amyloidosis: the insulin ball, amyloidoma","volume":"6","author":"Samlaska C","year":"2020","unstructured":"Samlaska C, Reber S, Murry T. Insulin-derived amyloidosis: the insulin ball, amyloidoma. JAAD Case Rep. 2020, 6:351-3. 10.1016\/j.jdcr.2020.02.011","journal-title":"JAAD Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2009.03711.x","article-title":"Localized cutaneous amyloid at an insulin injection site","volume":"34","author":"Lonsdale-Eccles AA","year":"2009","unstructured":"Lonsdale-Eccles AA, Gonda P, Gilbertson JA, Haworth AE. Localized cutaneous amyloid at an insulin injection site. Clin Exp Dermatol. 2009, 34:e1027-8. 10.1111\/j.1365-2230.2009.03711.x","journal-title":"Clin Exp Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2009.02.019","article-title":"Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report","volume":"40","author":"Yumlu S","year":"2009","unstructured":"Yumlu S, Barany R, Eriksson M, R\u00f6cken C. Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report. Hum Pathol. 2009, 40:1655-60. 10.1016\/j.humpath.2009.02.019","journal-title":"Hum Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2337\/cd21-0118","article-title":"Impact of insulin-derived amyloidosis on glycemic control and insulin dosing","volume":"40","author":"Estep A","year":"2022","unstructured":"Estep A, Uhrig J, Bower C, Jarrett R. Impact of insulin-derived amyloidosis on glycemic control and insulin dosing. Clin Diabetes. 2022, 40:380-4. 10.2337\/cd21-0118","journal-title":"Clin Diabetes"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1006\/jsbi.2000.4264","article-title":"Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants","volume":"130","author":"Morozova-Roche LA","year":"2000","unstructured":"Morozova-Roche LA, Zurdo J, Spencer A, et al.. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. J Struct Biol. 2000, 130:339-51. 10.1006\/jsbi.2000.4264","journal-title":"J Struct Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2016.1179183","article-title":"Insulin amyloid at injection sites of patients with diabetes","volume":"23","author":"Nilsson MR","year":"2016","unstructured":"Nilsson MR. Insulin amyloid at injection sites of patients with diabetes. Amyloid. 2016, 23:139-47. 10.1080\/13506129.2016.1179183","journal-title":"Amyloid"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.10.029","article-title":"Insulin-derived amyloidosis and poor glycemic control: a case series","volume":"127","author":"Nagase T","year":"2014","unstructured":"Nagase T, Iwaya K, Iwaki Y, et al.. Insulin-derived amyloidosis and poor glycemic control: a case series. Am J Med. 2014, 127:450-4. 10.1016\/j.amjmed.2013.10.029","journal-title":"Am J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.2c00174","article-title":"Amyloid fibrillation of insulin: amelioration strategies and implications for translation","volume":"5","author":"Fagihi MH","year":"2022","unstructured":"Fagihi MH, Bhattacharjee S. Amyloid fibrillation of insulin: amelioration strategies and implications for translation. ACS Pharmacol Transl Sci. 2022, 5:1050-61. 10.1021\/acsptsci.2c00174","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/db18-0846","article-title":"Extreme adhesion activity of amyloid fibrils induces subcutaneous insulin resistance","volume":"68","author":"Nakamura M","year":"2019","unstructured":"Nakamura M, Misumi Y, Nomura T, et al.. Extreme adhesion activity of amyloid fibrils induces subcutaneous insulin resistance. Diabetes. 2019, 68:609-16. 10.2337\/db18-0846","journal-title":"Diabetes"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/260862-amyloidoma-a-case-report-of-remote-insulin-derived-amyloidosis-in-the-setting-of-insulin-dependent-diabetes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T16:27:13Z","timestamp":1719764833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/260862-amyloidoma-a-case-report-of-remote-insulin-derived-amyloidosis-in-the-setting-of-insulin-dependent-diabetes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,30]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.63525","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,30]]}}}